Improving Oral Chemotherapy Adherence in Maintenance for Adolescents and Adults With Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma Using Text Messages
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 15
Healthy Volunteers: f
View:
• Age of 15 years or older at time of enrollment
• Diagnosed with ALL or T-cell lymphoblastic lymphoma
• Currently receiving treatment with pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (e.g., CALGB 10403). Study participation begins with the start of maintenance, so enrollment occurs prior to the start of maintenance. Patients in the pilot phase may have already started maintenance as long as the end of their maintenance therapy is scheduled to occur after the end of the 28-day pilot intervention.
Locations
United States
Illinois
University of Chicago Medicine Comprehensive Cancer Center
RECRUITING
Chicago
Contact Information
Primary
Clinical Trials Intake
cancerclinicaltrials@bsd.uchicago.edu
1-855-702-8222
Time Frame
Start Date: 2026-05-19
Estimated Completion Date: 2028-06-15
Participants
Target number of participants: 48
Treatments
Active_comparator: Efficacy Phase: High Intensity Messaging
Receives high-intensity text messaging for 2 cycles of treatment
Active_comparator: Efficacy Phase: Low Intensity Messaging
Receives no texts for 1st cycle and low-intensity texts for 2nd cycle
Experimental: Pilot Phase Arm
Participants receive high-intensity text messaging for 28 days
Related Therapeutic Areas
Sponsors
Leads: University of Chicago